Concepedia

Tarek Meniawy

TM

62

Publications

3.6K

Citations

32

H-Index

2013

Active since

Affiliations

Sir Charles Gairdner Hospital(Current)

The University of Western Australia

Edith Cowan University

Peter MacCallum Cancer Centre

Linear Clinical Research

Tarek Meniawy is an author at Sir Charles Gairdner Hospital specializing in oncology, medicine, and radiation oncology.

ORCID

Top concepts

Publications per year

2013–2024

62

Publications

62

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study

Jeffrey S. Weber, Matteo S. Carlino, Adnan Khattak et al. · The Lancet · 2024 · 598 citations

, , +7

Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma

Elin S. Gray, Helen Rizos, Anna Reid et al. · Oncotarget · 2015 · 322 citations · Full text

, , +18

Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial

John M. Kirkwood, Michele Del Vecchio, Jeffrey S. Weber et al. · Nature Medicine · 2023 · 174 citations · Full text

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

Jacobus Pfisterer, Catherine Shannon, Klaus Baumann et al. · The Lancet Oncology · 2020 · 157 citations

, , +8

A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis

Fraser Brims, Tarek Meniawy, Ian Duffus et al. · Journal of Thoracic Oncology · 2016 · 156 citations · Full text

Rows per page

1–5 of 62